AI Insight
Fertility clinics worldwide are advertising a controversial procedure involving young mitochondria to improve fertility outcomes, despite the lack of rigorous scientific studies on its safety and efficacy. Researchers have expressed alarm about the practice being offered commercially without proper validation through controlled clinical trials. The technique is being marketed to patients before the scientific community has established whether it works or what risks it might pose.
Why it matters
This raises significant ethical and safety concerns about unproven fertility treatments being offered to vulnerable patients seeking to conceive. The practice highlights gaps in regulation of reproductive technologies and the potential risks when commercial interests move faster than scientific validation.
Understand the Science
Nature, Published online: 28 July 2026; doi:10.1038/d41586-026-01935-5
Researchers are alarmed that the procedure, which has not been rigorously studied, is advertised by clinics around the world.
Source: Fertility clinics are offering young mitochondria in controversial fertility technique